Md. biotech firm to get European patent on leukemia drug candidate

A Maryland biotechnology company focused on cancer and sickle cell disease is set to receive a patent in Europe. The European Patent Office told GlycoMimetics Inc., which is based in Rockville, that it plans to grant a patent related to its drug candidate GMI-1271. The drug candidate is being evaluated in an ongoing phase 1 and …

from http://thedailyrecord.com/2017/07/06/maryland-glycomimetics-gmi-1271-europe/

Advertisements

Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s